About Vivace Therapeutics
Vivace Therapeutics is a private company based in San Mateo, California. It has reported $60,549,998 raised in four offerings on Form D since January 2015. Its chief executive is Shuang Qiao.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 28, 2025 | Mar 12, 2025 | $17,499,997of $34.9M target | 5 | $3.4M | EquityRule 506(b) | Form D ↗ |
| Dec 11, 2020 | Dec 23, 2020 | $29,999,993fully sold | 6 | $4.9M | EquityRule 506(b) | Form D ↗ |
| May 5, 2017 | May 18, 2017amended May 1, 2018 | $8,000,008of $24.9M target | 6 | $1.3M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 7, 2015 | Jan 20, 2015 | $5,050,000of $15.0M target | 3 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $60,549,998 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vivace Therapeutics's Form D filed Mar 12, 2025.
EH
Edward Hu
Director
JW
Jun Wu
Director
JS
Jake Simson
Director
TS
Tim Shannon
Director
CZ
Chenguang Zhou
Director
SQ
Shuang Qiao
Chief Executive Officer and director
Earlier filings also listed Leonard Post (director, last listed Dec 2020) and Sheng Ding (executive officer, last listed Jan 2015).